Načítá se...
Intravenous iron and erythropoiesis‐stimulating agents in haemodialysis: A systematic review and meta‐analysis
AIM: Higher dosages of erythropoiesis‐stimulating agents (ESAs) have been associated with adverse effects. Intravenous iron is used to optimize ESA response and reduces ESA doses in haemodialysis patients; this meta‐analysis evaluates the magnitude of this effect. METHODS: A literature search was pe...
Uloženo v:
| Vydáno v: | Nephrology (Carlton) |
|---|---|
| Hlavní autoři: | , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley and Sons Inc.
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5725690/ https://ncbi.nlm.nih.gov/pubmed/27699922 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/nep.12940 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|